Notably, our combined analysis of the above three databases identified seven cancer types in which PAN3-AS1 expression levels were upregulated, including COAD, cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), HNSC, liver hepatocellular carcinoma (LIHC), rectum adenocarcinoma (READ), and stomach adenocarcinoma (STAD). This evidence concerns the gene PAN3 and cancer.